Massive Neonatal Arterial Ischemic Stroke.


Journal

Pediatric neurology
ISSN: 1873-5150
Titre abrégé: Pediatr Neurol
Pays: United States
ID NLM: 8508183

Informations de publication

Date de publication:
07 2023
Historique:
received: 16 07 2022
revised: 17 03 2023
accepted: 19 03 2023
medline: 16 6 2023
pubmed: 24 4 2023
entrez: 23 04 2023
Statut: ppublish

Résumé

Massive infarction in adults is a devastating entity characterized by signs of extreme swelling of the brain's parenchyma. We explored whether a similar entity exists in neonates, which we call massive neonatal arterial ischemic stroke (M-NAIS), and assess its potential clinical implications. Prospective multicenter cohort study comprising 48 neonates with gestational age ≥35 weeks with middle cerebral artery (MCA) NAIS was performed. Diagnosis with magnetic resonance imaging (MRI) was performed within the first three days after symptom onset. The presence of signs of a space-occupying mass, such as brain midline shift and/or ventricular and/or extra-axial space collapse, was recorded. The volume of the infarct and brain midline shift were determined with semiautomatic procedures. Neurodevelopment was assessed at age 24 months. Fifteen (31%) neonates presented MRI signs of a space-occupying mass effect and were considered to have an M-NAIS. The relative volume (infarct volume/total brain volume) of the infarct was on average significantly greater in the M-NAIS subgroup (29% vs 4.9%, P < 0.001). Patients with M-NAIS consistently presented lesions involving the M1 arterial territory of the MCA and showed more apneic and tonic seizures, which had an earlier onset and lasted longer. Moderate to severe adverse neurodevelopmental outcomes were present in most M-NAIS cases (79% vs 6%, P < 0.001). M-NAIS appears to be a distinctive subtype of neonatal infarction, defined by characteristic neuroimaging signs. Neonates with M-NAIS frequently present a moderate to severe adverse outcome. Early M-NAIS identification would allow for prompt, specific rehabilitation interventions and would provide more accurate prognostic information to families.

Sections du résumé

BACKGROUND
Massive infarction in adults is a devastating entity characterized by signs of extreme swelling of the brain's parenchyma. We explored whether a similar entity exists in neonates, which we call massive neonatal arterial ischemic stroke (M-NAIS), and assess its potential clinical implications.
METHODS
Prospective multicenter cohort study comprising 48 neonates with gestational age ≥35 weeks with middle cerebral artery (MCA) NAIS was performed. Diagnosis with magnetic resonance imaging (MRI) was performed within the first three days after symptom onset. The presence of signs of a space-occupying mass, such as brain midline shift and/or ventricular and/or extra-axial space collapse, was recorded. The volume of the infarct and brain midline shift were determined with semiautomatic procedures. Neurodevelopment was assessed at age 24 months.
RESULTS
Fifteen (31%) neonates presented MRI signs of a space-occupying mass effect and were considered to have an M-NAIS. The relative volume (infarct volume/total brain volume) of the infarct was on average significantly greater in the M-NAIS subgroup (29% vs 4.9%, P < 0.001). Patients with M-NAIS consistently presented lesions involving the M1 arterial territory of the MCA and showed more apneic and tonic seizures, which had an earlier onset and lasted longer. Moderate to severe adverse neurodevelopmental outcomes were present in most M-NAIS cases (79% vs 6%, P < 0.001).
CONCLUSIONS
M-NAIS appears to be a distinctive subtype of neonatal infarction, defined by characteristic neuroimaging signs. Neonates with M-NAIS frequently present a moderate to severe adverse outcome. Early M-NAIS identification would allow for prompt, specific rehabilitation interventions and would provide more accurate prognostic information to families.

Identifiants

pubmed: 37087915
pii: S0887-8994(23)00091-7
doi: 10.1016/j.pediatrneurol.2023.03.013
pii:
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5-10

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Auteurs

Gemma Arca (G)

Department of Neonatology, Hospital Clínic, IDIBAPS, Barcelona, Spain; NeNe Foundation, Madrid, Spain. Electronic address: garca@clinic.cat.

Christian Núñez (C)

Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain; Mental Health Research Group, Institut d'Investigació Biomèdica-Sant Pau (IIB-Sant Pau), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

Christian Stephan-Otto (C)

Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain; Pediatric Computational Imaging Group (PeCIC), Hospital Sant Joan de Déu, Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental, Madrid, Spain.

Juan Arnaez (J)

NeNe Foundation, Madrid, Spain; Neonatology Service, Burgos University Hospital, Burgos, Spain; Professor of the Ibero-American Society of Neonatology (SIBEN), New Jersey, USA.

Thais Agut (T)

NeNe Foundation, Madrid, Spain; Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain; Department of Neonatology, Hospital Sant Joan de Déu, Esplugues de Llobregat, Spain.

Malaika Cordeiro (M)

Department of Neonatology, La Paz University Hospital, Madrid, Spain.

Nuria Boronat (N)

Department of Neonatology, University and Politechnic Hospital La Fe, Health Research Institute La Fe, Valencia, Spain.

Simón Lubián-López (S)

NeNe Foundation, Madrid, Spain; Department of Neonatology, Puerta del Mar University Hospital, Cádiz, Spain; Department of Pediatrics, Institute for Research and Innovation in Biomedical Sciences (INiBICA), Cádiz, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain.

Isabel Benavente-Fernández (I)

NeNe Foundation, Madrid, Spain; Department of Neonatology, Puerta del Mar University Hospital, Cádiz, Spain; Department of Pediatrics, Institute for Research and Innovation in Biomedical Sciences (INiBICA), Cádiz, Spain.

Eva Valverde (E)

NeNe Foundation, Madrid, Spain; Department of Neonatology, La Paz University Hospital, Madrid, Spain.

Alfredo Garcia-Alix (A)

NeNe Foundation, Madrid, Spain; Professor of the Ibero-American Society of Neonatology (SIBEN), New Jersey, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH